| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3120ae9cab5bb4831f0cc16288966367 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-36 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-36 |
| filingDate |
2018-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bae1d324d78cacdfb70625565c5d381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a90065b505c6300808dd8a10083e5f5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_335b50c4fd9cad1b6a9f362fc4dc4935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff40db19deb4e370d9b6ad8e75a097b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7708f49cda8c72107477119b17a39af9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4111787d524e9da540c5b5775cee7a73 |
| publicationDate |
2020-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3710486-A1 |
| titleOfInvention |
Factor x binders enhancing fx activation |
| abstract |
The application relates to unique FX binding molecules, such as antibodies and fragments thereof which are useful in the treatment of haemophilia. |
| priorityDate |
2017-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |